Induction of fear extinction with hippocampal-lnfralimbic BDNF

Science

Volumn 328, Issue 5983, 2010, Pages 1288-1290

  Peters, Jamie ^a   Dieppa Perea, Laura M ^a   Melendez, Loyda M ^a   Quirk, Gregory J ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

BRAIN; LEARNING; MEMORY; NEUROLOGY; RODENT;

ARTICLE; AUDITORY STIMULATION; BRAIN REGION; CONDITIONING; FEAR; HIPPOCAMPUS; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REINFORCEMENT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CONDITIONING (PSYCHOLOGY); EXCITATORY AMINO ACID ANTAGONISTS; EXTINCTION, PSYCHOLOGICAL; FEAR; HIPPOCAMPUS; HUMANS; MALE; MEMORY; NEURAL PATHWAYS; PIPERAZINES; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS;

RATTUS;

EID: 77953282058     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1186909     Document Type: Article

References (28)

1. F. Sotres-Bayon, C. K. Cain, J. E. LeDoux, Biol. Psychiatry 60, 329 (2006).
2. G. J. Quirk, D. Mueller, Neuropsychopharmacology 33, 56 (2008).
3. M. R. Milad, G. J. Quirk, Nature 420, 70 (2002).
4. F. Sotres-Bayon, L. Diaz-Mataix, D. E. Bush, J. E. LeDoux, Cereb. Cortex 19, 474 (2009).
5. T. W. Bredy et al., Learn. Mem. 14, 268 (2007).
6. C. R. Bramham, E. Messaoudi, Prog. Neurobiol. 76, 99 (2005).
7. S. Duvarci, K. Nader, J. Neurosci. 24, 9269 (2004).
8. A. Burgos-Robles, I. Vidal-Gonzalez, E. Santini, G. J. Quirk, Neuron 53, 871 (2007).
9. W. A. Falls, M. J. Miserendino, M. Davis, J. Neurosci. 12, 854 (1992).
10. E. Santini, R. U. Muller, G. J. Quirk, J. Neurosci. 21, 9009 (2001).
11. I. B. Black, J. Neurobiol. 41, 108 (1999).
12. E. S. Levine, R. A. Crazier, I. B. Black, M. R. Plummer, Proc. Natl. Acad. Sci. USA 95, 10235 (1998).
13. C. Herry, R. Garcia, J. Neurosci. 22, 577 (2002).
14. W. B. Hoover, R. P. Vertes, Brain Struct. Fund. 212, 149 (2007).
15. J. P. Chhatwal, L. Stanek-Rattiner, M. Davis, K. J. Ressler, Nat. Neurosci. 9, 870 (2006).
16. H. S. Phillips, J. M. Hains, G. R. Laramee, A. Rosenthal, J. W. Winslow, Science 250, 290 (1990).
17. S. A. Heldt, L. Stanek, J. P. Chhatwal, K. J. Ressler, Mol. Psychiatry 12, 656 (2007).
18. J. F. McGinty, T. W. Whitfield Jr., W. J. Berglind, Brain Res. 1314, 183 (2010).
19. E. Messaoudi, S. W. Ying, T. Kanhema, S. D. Croll, C. R. Bramham, J. Neurosci. 22, 7453 (2002).
20. R. Garcia, G. Spennato, L. Nilsson-Todd, J. L. Moreau, O. Deschaux, Neurobiol. Learn. Mem. 89, 560 (2008).
21. E. Likhtik, D. Popa, J. Apergis-Schoute, G. A. Fidacaro, D. Paré, Nature 454, 642 (2008).
22. A. M. Rasmusson, L. Shi, R. Duman, Neuropsychopharmacology 27, 133 (2002).
23. E. Santini, G. J. Quirk, J. T. Porter, J. Neurosci. 28, 4028 (2008).
24. R. Kalisch et al., J. Neurosci. 26, 9503 (2006).
25. M. R. Milad et al., Biol. Psychiatry 66, 1075 (2009).
26. F. Soliman et al., Science 327, 863 (2010).
27. Z. Y. Chen et al., Science 314, 140 (2006).
28. We thank V. Garcia, D. Merced, N. Padilla, C. Rodriguez, J. Rodriguez-Romaguera, D. Sierra-Mercado, and A. Torrado for technical assistance and D. Paré and J. F. McGinty for helpful comments. Supported by NIH grants MH058883, MH081975, NS043011, MH083516, MH085383, and RR003051 and by the University of Puerto Rico.